A recent study by Cui et al. highlighted that interstitial CAFs and microvascular endothelial cells co-express IDO1 in esophageal cancer, which may be an of the mechanisms that cancer cells inhibit host anti-tumor immunity [157]. This evidence concerns the gene IDO1 and cancer.